73
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Global Burden of Dengue: an analysis from the Global Burden of Disease Study 2013

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Dengue is the most common arbovirus infection globally, but its burden is poorly quantified. We estimated dengue mortality, incidence, and burden for the Global Burden of Disease Study 2013.

          Methods

          We modelled mortality from vital registration, verbal autopsy, and surveillance data using the Cause of Death Ensemble Modelling tool. We modelled incidence from officially reported cases, and adjusted our raw estimates for under-reporting based on published estimates of expansion factors. In total, we had 1780 country-years of mortality data from 130 countries, 1636 country-years of dengue case reports from 76 countries, and expansion factor estimates for 14 countries.

          Findings

          We estimated an average of 9221 dengue deaths per year between 1990 and 2013, increasing from a low of 8277 (95% uncertainty estimate 5353–10 649) in 1992, to a peak of 11 302 (6790–13 722) in 2010. This yielded a total of 576 900 (330 000–701 200) years of life lost to premature mortality attributable to dengue in 2013. The incidence of dengue increased greatly between 1990 and 2013, with the number of cases more than doubling every decade, from 8∙3 million (3∙3 million–17∙2 million) apparent cases in 1990, to 58∙4 million (23∙6 million–121∙9 million) apparent cases in 2013. When accounting for disability from moderate and severe acute dengue, and post-dengue chronic fatigue, 566 000 (186 000–1 415 000) years lived with disability were attributable to dengue in 2013. Considering fatal and non-fatal outcomes together, dengue was responsible for 1∙14 million (0∙73 million–1∙98 million) disability-adjusted life-years in 2013.

          Interpretation

          Although lower than other estimates, our results offer more evidence that the true symptomatic incidence of dengue probably falls within the commonly cited range of 50 million to 100 million cases per year. Our mortality estimates are lower than those presented elsewhere and should be considered in light of the totality of evidence suggesting that dengue mortality might, in fact, be substantially higher.

          Related collections

          Author and article information

          Journal
          101130150
          27022
          Lancet Infect Dis
          Lancet Infect Dis
          The Lancet. Infectious diseases
          1473-3099
          1474-4457
          1 September 2016
          10 February 2016
          June 2016
          01 December 2016
          : 16
          : 6
          : 712-723
          Affiliations
          [1 ]Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Avenue, Suite 600, Seattle, WA 8121 USA
          [2 ]Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA 02454-9110 USA
          [3 ]Department of Public Health, Erasmus MC University Medical Center Rotterdam, P.O. box 2040, 3000 CA Rotterdam, The Netherlands
          [4 ]Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, United Kingdom
          [5 ]Fogarty International Center, National Institutes of Health, Bethesda, MD 20892-2220, USA
          [6 ]College of Public Health and Tropical Medicine, Jazan University, Al Zahur Street, Jizan-Sabya Highway, Jazan, Saudi Arabia
          [7 ]University of São Paulo, Hospital Universitário, Av. Lineu Prestes 2565 - 3o andar, São Paulo, Brazil 05508-000
          [8 ]Colombian National Health Observatory, Av. Calle 26#51-20 bloque B. Of 218, Bogotá, DC, Colombia 111101;
          [9 ]Epidemiology and Public Health Evaluation Group, Public Health Department, Universidades Nacional de Colombia, Carrera 30#45-03. Ciudad Universitaria, Facultad de Medicina, Oficina 150, Bogotá, Colombia 111101
          [10 ]Department of Molecular Parasitology and Tropical Diseases, School of Medicine, Taipei Medical University, Taipei, Taiwan
          [11 ]Department of Epidemiology and Preventive Medicine, Monash University, The Alfred Centre, 99 Commercial Road, Melbourne, VIC, Australia 3004
          [12 ]Victorian Infectious Diseases Service, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, VIC Australia 3000
          [13 ]College of Medicine, Alfaisal University, Takhasusi Road, Riyadh-11533, Kingdom of Saudi Arabia
          [14 ]Saudi Ministry of Health, Prince Abdurrahman bin Abdul Aziz Street, Riyadh-11176, Kingdom of Saudi Arabia
          [15 ]Contech International Health Consultants, 2G- Model Town, Lahore, Pakistan
          [16 ]Contech School of Public Health, 54-B, HBFC Colony, Faisal Town, Lahore, Pakistan
          [17 ]Department of Internal Medicine, Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria 23433
          [18 ]National Center of Neurology and Psychiatry, 4-1-1, Ogawahigashi, Kodaira, Tokyo, Japan 1878551
          Author notes
          [* ]Corresponding author, stanaway@ 123456uw.edu , (+1) 206 897 3818
          Article
          PMC5012511 PMC5012511 5012511 ems69753
          10.1016/S1473-3099(16)00026-8
          5012511
          26874619
          350ed62e-b9c6-4fc8-aa88-2d49340722d2
          History
          Categories
          Article

          Comments

          Comment on this article